Syntaxis Company
Syntaxis is committed to discovering, developing and commercialising novel therapeutics that enhance recovery of brain functions after stroke.
Technology:
NeuroTech
Industry:
Biotechnology, Health Care, Science and Engineering
Headquarters:
Lund, Skane Lan, Sweden
Founded Date:
2017-01-01
Employees Number:
1-10
Investors Number:
2
Total Funding:
€200K
Estimated Revenue:
Less than $1M
Last Funding Type:
Seed
Register and Claim Ownership